Drug-labels.com

Odan-Chloramphenicol Product Monograph

The product monograph is written for health professionals. Plain-language information for patients is in the patient medication information.

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
0.5 mg, 10 mg
Active ingredient:

Product Monograph - Odan-Chloramphenicol

ADVERSE REACTIONS

Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.

OVERDOSAGE

For management of a suspected drug overdose, contact your regional Poison Control Centre.

4

DOSAGE AND ADMINISTRATION

Solution:

Two drops applied to the affected eye(s) every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night for the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye(s) appears normal.

Ointment:

Apply a small amount (1 cm strip) to the lower conjunctiva sac(s) at bedtime as a supplement to the drops.

AVAILABILITY

Each mL of sterile ophthalmic solution contains: Chloramphenicol USP 0.5 % (5 mg/mL); and the following non-medicinal ingredients: boric acid, sodium borate, sodium chloride, sodium hydroxide (to adjust pH) and purified water. Available in 15 mL plastic dropper bottles.

Each gram of sterile ophthalmic ointment contains: Chloramphenicol USP 1% (10 mg/g); and the following non-medicinal ingredients: mineral oil, white petrolatum and polysorbate 60. Available in 3.5 grams tubes.

STORAGE CONDITIONS

Solution: Store between 2°C and 8°C until dispensed. After dispensing, keep the solution at room temperature (between 15°C and 30°C) for 21 days during treatment; after that period, discard unused portion. Protect from light.

Ointment: Store between 15°C and 30°C. Keep container tightly closed.

Click to Zoom In

5

PHARMACEUTICAL INFORMATION

Structural Formula:

Chemical Name: 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4- nitrophenyl)ethyl]-, [R-(R*,R*)]-acetamide

Molecular Formula: C11H12Cl2N2O5

Molecular Weight: 323.13

Description: Fine, white to grayish-white or yellowish-white, needle-like crystals or elongated plates. Freely soluble in alcohol, in propylene glycol, in acetone, and in ethyl acetate; slightly soluble in water.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00622958

Revision date stated in the text: July 17, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Odan-Chloramphenicol

Rx or OTC
Prescription (Rx)?
DIN 00622958, 00627720
Schedule(s) PRESCRIPTION
Active ingredient(s) Chloramphenicol
Dosage form(s) Liquid, Ointment
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01A Antiinfective ophthalmologics
        1. S01AA Antibiotics, ophthalmologic
          1. S01AA01 Chloramphenicol
Company ODAN LABORATORIESLTD
Current status Dormant
Current status date June 22, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
00622958 0.5 MG Liquid Dormant June 22, 2017
00627720 10 MG Ointment Dormant June 22, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.